Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018593306> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2018593306 endingPage "13650" @default.
- W2018593306 startingPage "13641" @default.
- W2018593306 abstract "Inosine 5'-monophosphate dehydrogenase (IMPDH) is the rate-limiting enzyme in de novo purine biosynthesis. IMPDH activity results from expression of two isoforms. Type I is constitutively expressed and predominates in normal resting cells, while Type II is selectively up-regulated in neoplastic and replicating cells. Inhibitors of IMPDH activity selectively targeting the Type II isoform have great potential as cancer chemotherapeutic agents. For this study, an expression system was developed which yields 35-50 mg of soluble, purified recombinant Type I and II protein from 1 L of bacteria. In addition, three 1,5-diazabicyclo[3.1.0]hexane-2,4-diones were synthesized and shown to act as specific inhibitors of human recombinant Type II IMPDH. The agents are competitive inhibitors with respect to the endogenous substrate IMP and K(i) values range from 5 to 44 microM but were inactive as inhibitors of the Type I isoform at concentrations ranging from 0.5 to 500 microM. IC(50) values for recombinant Type II inhibition were determined and compared to IC(50) values obtained from Molt-4 cell extracts of IMPDH. Cytotoxicity assays revealed that the compounds inhibited Molt-4 leukemia growth with ED(50) values of 3.2-7.6 microM. Computational docking studies predict that the compounds bind to IMPDH in the IMP-binding site, although interactions with residues differ from those previously determined to interact with bound IMP. While all residues predicted to interact directly with the bound compounds are conserved in the Type I and Type II isoforms, sequence divergence within a helix adjacent to the active site may contribute to the observed selectivity for the human Type II isoform. These compounds represent the first class of selective IMPDH Type II inhibitors which may serve as lead compounds for the development of isoform-selective cancer chemotherapy." @default.
- W2018593306 created "2016-06-24" @default.
- W2018593306 creator A5000829756 @default.
- W2018593306 creator A5004786122 @default.
- W2018593306 creator A5042412815 @default.
- W2018593306 creator A5077971912 @default.
- W2018593306 date "2000-10-21" @default.
- W2018593306 modified "2023-09-26" @default.
- W2018593306 title "Selective Inhibition of Human Molt-4 Leukemia Type II Inosine 5‘-Monophosphate Dehydrogenase by the 1,5-Diazabicyclo[3.1.0]hexane-2,4-diones" @default.
- W2018593306 cites W129214877 @default.
- W2018593306 cites W1481342915 @default.
- W2018593306 cites W1519817796 @default.
- W2018593306 cites W1578213890 @default.
- W2018593306 cites W1586135101 @default.
- W2018593306 cites W1986647193 @default.
- W2018593306 cites W2021474612 @default.
- W2018593306 cites W2050116381 @default.
- W2018593306 cites W2102575391 @default.
- W2018593306 cites W2118069060 @default.
- W2018593306 cites W2280449939 @default.
- W2018593306 cites W2951011543 @default.
- W2018593306 cites W3004938882 @default.
- W2018593306 doi "https://doi.org/10.1021/bi0004044" @default.
- W2018593306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11076502" @default.
- W2018593306 hasPublicationYear "2000" @default.
- W2018593306 type Work @default.
- W2018593306 sameAs 2018593306 @default.
- W2018593306 citedByCount "11" @default.
- W2018593306 crossrefType "journal-article" @default.
- W2018593306 hasAuthorship W2018593306A5000829756 @default.
- W2018593306 hasAuthorship W2018593306A5004786122 @default.
- W2018593306 hasAuthorship W2018593306A5042412815 @default.
- W2018593306 hasAuthorship W2018593306A5077971912 @default.
- W2018593306 hasConcept C104317684 @default.
- W2018593306 hasConcept C141071460 @default.
- W2018593306 hasConcept C181199279 @default.
- W2018593306 hasConcept C185592680 @default.
- W2018593306 hasConcept C2776317432 @default.
- W2018593306 hasConcept C2777610669 @default.
- W2018593306 hasConcept C2778033501 @default.
- W2018593306 hasConcept C2911091166 @default.
- W2018593306 hasConcept C38596361 @default.
- W2018593306 hasConcept C40767141 @default.
- W2018593306 hasConcept C53345823 @default.
- W2018593306 hasConcept C55493867 @default.
- W2018593306 hasConcept C71240020 @default.
- W2018593306 hasConcept C71924100 @default.
- W2018593306 hasConcept C86803240 @default.
- W2018593306 hasConceptScore W2018593306C104317684 @default.
- W2018593306 hasConceptScore W2018593306C141071460 @default.
- W2018593306 hasConceptScore W2018593306C181199279 @default.
- W2018593306 hasConceptScore W2018593306C185592680 @default.
- W2018593306 hasConceptScore W2018593306C2776317432 @default.
- W2018593306 hasConceptScore W2018593306C2777610669 @default.
- W2018593306 hasConceptScore W2018593306C2778033501 @default.
- W2018593306 hasConceptScore W2018593306C2911091166 @default.
- W2018593306 hasConceptScore W2018593306C38596361 @default.
- W2018593306 hasConceptScore W2018593306C40767141 @default.
- W2018593306 hasConceptScore W2018593306C53345823 @default.
- W2018593306 hasConceptScore W2018593306C55493867 @default.
- W2018593306 hasConceptScore W2018593306C71240020 @default.
- W2018593306 hasConceptScore W2018593306C71924100 @default.
- W2018593306 hasConceptScore W2018593306C86803240 @default.
- W2018593306 hasIssue "45" @default.
- W2018593306 hasLocation W20185933061 @default.
- W2018593306 hasLocation W20185933062 @default.
- W2018593306 hasOpenAccess W2018593306 @default.
- W2018593306 hasPrimaryLocation W20185933061 @default.
- W2018593306 hasRelatedWork W1966876488 @default.
- W2018593306 hasRelatedWork W1999957271 @default.
- W2018593306 hasRelatedWork W2016628627 @default.
- W2018593306 hasRelatedWork W2037807868 @default.
- W2018593306 hasRelatedWork W2038831974 @default.
- W2018593306 hasRelatedWork W2067836029 @default.
- W2018593306 hasRelatedWork W2078646031 @default.
- W2018593306 hasRelatedWork W2085017307 @default.
- W2018593306 hasRelatedWork W2091245075 @default.
- W2018593306 hasRelatedWork W2426772781 @default.
- W2018593306 hasVolume "39" @default.
- W2018593306 isParatext "false" @default.
- W2018593306 isRetracted "false" @default.
- W2018593306 magId "2018593306" @default.
- W2018593306 workType "article" @default.